Summary
New techniques of sural nerve photography and fluorescein angiography which are able to provide an index of nerve blood flow have been developed. Under local anaesthetic, 3 cm of sural nerve was exposed at the ankle using an operating microscope. Without disturbing the epineurium, vessels were identified and photographed at a standard magnification (× 30). These were independently graded by an ophthalmologist not otherwise involved with the study. Fluorescein angiography was then carried out on the exposed nerve. The fluorescein appearance time and intensity of fluorescence were quantified, using computer analysis of digitised images. Thirteen subjects with chronic sensory motor neuropathy, five non-neuropathic diabetic and nine normal control subjects were studied. The mean epineurial vessel pathology score of the neuropathic group was significantly higher than the combined normal control and non-neuropathic diabetic groups (p <0.01). Direct epineurial arteriovenous shunting was observed in six neuropathic and one non-neuropathic diabetic patients and not in any of the normal control subjects. The nerve fluorescein appearance time was significantly delayed in subjects with chronic sensory motor neuropathy (51.5 ± 12 s) compared to both normal (34.7 ± 9 s, p <0.01) and non-neuropathic diabetic subjects (33.4 ± 11 s, p <0.025). The mean intensity of fluorescence at 96, 252 and 576 s, was significantly lower in subjects with chronic sensory motor neuropathy compared with both of the other groups (p <0.05). The epineurial vessel pathology score was significantly related to reduced sural (p <0.01) and peroneal (p <0.001) nerve conduction velocities, elevated vibration (p <0.01) and thermal (p <0.001) perception and the severity of retinopathy (p <0.002). The fluorescein appearance time was significantly related to reduced sural sensory (p <0.02) conduction velocity, elevated vibration (p <0.01) perception and epineurial vessel (p <0.002) pathology score, but it failed to relate to peroneal motor (p = 0.06) conduction velocity, thermal (p = 0.1) perception and the severity of retinopathy (p = 0.3). Intensity of fluorescence was significantly related to fluorescein appearance time (at 96 s, p <0.001; at 576 s, p <0.05) but did not relate to measures of neuropathic severity. These techniques have enabled us to observe that epineurial vessel anatomy is abnormal and that nerve blood flow is impaired in subjects with chronic sensory motor neuropathy. In addition epineurial arterio-venous shunting may be a feature of diabetic neuropathy. These techniques may further be applied to study nerve blood flow in early diabetic neuropathy.
Article PDF
Similar content being viewed by others
References
Dyck PJ (1989) Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? Neurology 39: 111–118
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278
Malik RA, Tesfaye S, Thompson SD et al. (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36: 454–459
Yasuda H, Dyck PJ (1987) Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37: 20–28
Britland ST, Young RJ, Sharma AK, Clarke BF (1990) Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39: 909–913
Timperly WR, Boulton AJM, Davies Jones GAB, Jarrat JA, Ward JD (1985) Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol 38: 1030–1038
Johnson PC, Doll SC, Cromey DW (1986) Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450–457
Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R (1986) Fibre loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425–439
Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92–102
Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMJ 293: 1053–1054
Tesfaye S, Harris N, Wilson RM, Ward JD (1992) Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 35: 155–159
Young MJ, Veves A, Walker MG, Boulton AJM (1992) Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 35: 1146–1150
Lange K, Boyd LJ (1943) Use of fluorescein method in establishment of diagnosis and prognosis of peripheral vascular disease. Arch Intern Med 74: 175–184
Stolar CH, Randolph JG (1978) Evaluation of ischaemic bowel viability with a fluorescent technique. J Pediatr Surg 13: 221–225
Marfuggi RA, Greenspan M (1981) Reliable intraoperative prediction of intestinal viability using a fluorescent indicator. Surg Gynecol Obstet 152: 33–35
McCraw JD, Myers B, Shanklin KD (1977) The value of fluorescein in predicting the viability of arterialized flaps. Plast Reconstr Surg 35: 177–182
Silverman DG, LaRossa DD, Barlow CH, Bering TG, Popky LM, Smith TC (1980) Quantification of tissue fluorescein delivery and prediction of flap viability with the fiberoptic dermofluorometer. Plast Reconstr Surg 66: 545–553
Singer ER, Lewis CM, Franklin JD, Lynch JB (1978) Fluorescein test for prediction of flap viability in breast reconstructions. Plast Reconstr Surg 61: 371–375
Myers MB (1962) Prediction of skin sloughs at the time of operation with the use of fluorescein dye. Surgery 51: 158–162
Yao ST, Hobbs JT, Irvine WT (1969) Ankle systolic measurements in arterial disease affecting the lower extremities. Br J Surg 56: 676–679
Arezzo JC, Schaumburg HH, Laudadio C (1986) Thermal sensitivity tester: device for quantitative assessment for thermal sense in diabetic neuropathy. Diabetes 35: 590–592
O'Brien IAD, O'Hare P, Corrall RJM (1986) Heart rate variability in healthy subjects: effect of age and derivation of normal ranges for tests of autonomic function. Br Heart J 55: 348–354
Dyck PJ (1988) Detection, characterization, and staging of polyneuropathy. Muscle Nerve 11: 21–32
Malmgren LT, Olsson Y (1980) Differences between the peripheral and central nervous system in permeability to sodium fluorescein. J Comp Neurol 191: 103–117
Williamson JR, Vogler NJ, Kilo C (1971) Microvascular disease in diabetes. Med Clinics North Am 55: 847–860
Raff MC, Sangalang V, Asbury AK (1968) Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol 18: 487–499
Dreyfus PM, Hakim S, Adams RD (1957) Diabetic ophthalmoplegia: report of case, with postmortem study and comments in vascular supply of human oculomotor nerve. Arch Neurol Psych 77: 337–349
Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93: 555–566
Korthals JK, Gieron MA, Dyck PJ (1980) Intima of epineurial arterioles is increased in diabetic polyneuropathy. Neurology 38: 1582–1586
Landau J, Davis E (1960) The small blood vessels of the conjunctiva in diabetes mellitus. Lancet II: 731–734
Novotny HR, Alvis DL (1961) A method of photographing fluorescence in circulating blood in human retina. Circulation 24: 82–86
Lawrence PF, McFarland DC, Seeger JM, Lowry SF (1980) Evaluation of extremity ischaemia by skin fluorescence. Surg Form 31: 349
Lowry K, Kirkpatrick JF, Thoroughman JC (1964) Evaluation of peripheral vascular disease using intraarterial fluorescein. Am Surg 30: 35–39
Silverman DG, Cedrone FA, Hurford AB, Bering TG, LaRossa DD (1981) Monitoring tissue elimination of fluorescein with the perfusion fluorometer: a new method to assess capillary blood flow. Surgery 90: 409–417
Perbeck L, Lewis DH, Thulin L, Tyden G (1985) Correlation between fluorescein flowmetry, 133Xenon clearance and electromagnetic flow measurements: a study in the intestine of the pig. Clin Physiol 5: 293–299
Parving HH, Viberti CG, Keen H, Christiansen JS, Lassen NA (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949
Kohner EM (1976) The problems of retinal blood flow in diabetes. Diabetes 25 [Suppl 2]: 839–844
Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA (1983) Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Royal Soc Med 76: 1011–1014
Ward JD, Boulton AJM (1987) Peripheral vascular abnormalities and diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegard AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 89–93
Edmonds ME, Roberts VC, Watkins JP (1982) Blood flow in the diabetic neuropathic foot. Diabetologia 22: 9–15
Boulton AJM, Scarpello JHB, Ward JD (1982) Venous oxygenation in the diabetic neuropathic foot: evidence of arterio-venous shunting? Diabetologia 22: 6–8
Sladky JT, Tschoepe RL, Greenberg JH, Brown MJ (1991) Peripheral neuropathy after chronic endoneurial ischemia. Ann Neurol 29: 272–278
Tesfaye S, Malik R, Harris N, Jakubowski J, Wilson RM, Ward JD (1992) Epineurial new vessel formation following institution of insulin therapy (abstract). Diabetologia 35 [Suppl 1]: A158
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tesfaye, S., Harris, N., Jakubowski, J.J. et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36, 1266–1274 (1993). https://doi.org/10.1007/BF00400804
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400804